Viewing Study NCT03810066


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2025-12-26 @ 9:12 AM
Study NCT ID: NCT03810066
Status: COMPLETED
Last Update Posted: 2024-05-09
First Post: 2019-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)
Sponsor: University Hospital, Essen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module